💨 Abstract

The Supreme Court of India has allowed a petitioner to file objections to the rules framed by the government regarding clinical trials of medicines and vaccines, expressing concern over their conduct in poor countries. The rules, framed in 2019 and amended in 2024, aim to improve patient safety protocols and ensure global standards.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖